SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-197837
Filing Date
2020-07-23
Accepted
2020-07-23 16:48:03
Documents
4
Effectiveness Date
2020-07-23

Document Format Files

Seq Description Document Type Size
1 S-8 d31393ds8.htm S-8 78212
2 EX-5.1 d31393dex51.htm EX-5.1 7273
3 EX-23.1 d31393dex231.htm EX-23.1 1716
4 GRAPHIC g31393c1.jpg GRAPHIC 12570
  Complete submission text file 0001193125-20-197837.txt   100247
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-240048 | Film No.: 201044067
SIC: 2836 Biological Products, (No Diagnostic Substances)